SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-013731
Filing Date
2021-03-05
Accepted
2021-03-05 16:05:18
Documents
2
Period of Report
2021-03-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea137109-8k_immunebio.htm 8-K 18956
2 PRESS-RELEASE DATED MARCH 4, 2021 ea137109ex99-1_immunebio.htm EX-99.1 9501
  Complete submission text file 0001213900-21-013731.txt   29603
Mailing Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037
Business Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38793 | Film No.: 21718498
SIC: 2836 Biological Products, (No Diagnostic Substances)